Novel spectacle lens design

DEVICE8 trials

Sponsors

SightGlass Vision, Inc.

Conditions

Juvenile MyopiaMyopiaMyopia ProgressionMyopia, Progressive

Unknown Phase

Control of Myopia Using Novel Spectacle Lens Designs

Active, not recruitingNCT03623074

SightGlass Vision, Inc.Juvenile Myopia

Start: 2018-07-16End: 2026-12-31Updated: 2026-05-05

Choroidal Response to Novel Spectacle Lens to Control Myopia Progression

Active, not recruitingNCT03818880

SightGlass Vision, Inc.Myopia, Progressive

Start: 2018-12-18End: 2026-12-31Target: 10Updated: 2026-05-05

CYPRESS Efficacy and Safety Study Extension

Active, not recruitingNCT04947735

SightGlass Vision, Inc.Juvenile Myopia, Myopia

Start: 2021-07-19End: 2026-12-31Target: 200Updated: 2026-05-05

Assessment of DOT Spectacles in Chinese Children

Active, not recruitingNCT05562622

SightGlass Vision, Inc.Juvenile Myopia, Myopia

Start: 2023-02-05End: 2027-12-31Updated: 2026-07-13

Spectacle Lens Visual Acuity Assessments Study

Active, not recruitingNCT05650190

SightGlass Vision, Inc.Juvenile Myopia, Myopia, Myopia Progression

Start: 2022-12-08End: 2026-12-31Updated: 2026-05-05

Assessment of DOT Spectacles in Chinese Children Extension

RecruitingNCT07008001

SightGlass Vision, Inc.Juvenile Myopia, Myopia

Start: 2025-08-01End: 2026-12-31Target: 175Updated: 2025-12-29

Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses

RecruitingNCT07229352

SightGlass Vision, Inc.Juvenile Myopia, Myopia, Myopia Progression

Start: 2026-02-02End: 2027-07-01Target: 20Updated: 2026-04-30

Children's Viewing Behavior

RecruitingNCT07229365

SightGlass Vision, Inc.Juvenile Myopia, Myopia, Myopia Progression

Start: 2025-12-22End: 2027-07-01Target: 20Updated: 2026-04-30

Related Papers

Control of myopia using diffusion optics spectacle lenses: 4-year results of a multicentre randomised controlled, efficacy and safety study (CYPRESS)

BMJ Open Ophthalmology2024-10-0123 citations

Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS)

British Journal of Ophthalmology2022-09-01131 citations